Form 4: AVITA Medical CFO Buys Shares via ESPP
Statement of Changes in Beneficial Ownership
AVITA Medical's CFO, David O'Toole, acquired 5,000 shares through the company's Employee Stock Purchase Plan.
Summary
- David O'Toole, Chief Financial Officer of AVITA Medical, Inc., acquired 5,000 shares of common stock.
- The acquisition occurred on May 29, 2026, under the company's Employee Stock Purchase Plan (ESPP).
- The purchase price was $3.0515 per share, representing 85% of the closing stock price on December 1, 2025.
- This transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
- Following this transaction, O'Toole beneficially owns 150,927 shares, which includes unvested RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider transaction through an employee plan rather than a strategic company announcement.
Positives
- Insider purchase through an ESPP indicates employee confidence and participation in the company's stock.
- Acquisition at a discount (85% of closing price) is a benefit to the employee.
- The transaction is structured to be exempt from short-swing profit rules, suggesting proper planning.
Negatives
- The filing does not contain any negative information.
Risks
- The filing does not explicitly mention any risks.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that insider transactions via ESPPs are common for employee compensation and retention, reflecting a standard practice within the biotechnology and medical device sectors.
Stakeholder Impact
- Shareholders: The transaction itself does not directly impact share price but reflects ongoing employee engagement.
- Employees: Participation in the ESPP is a benefit offered to employees.
- Management: The CFO is actively participating in employee stock purchase programs.
Next Steps
- Continued participation in the ESPP for future purchase periods, if applicable.
Key Dates
| Date | Description |
|---|---|
| 2025-12-01 | Purchase date of the offering period for the ESPP. |
| 2026-05-29 | Transaction date for the acquisition of common stock. |
| 2026-06-01 | Date of signature for the filing. |
Keywords
AVITA Medical, RCEL, Form 4, Insider Trading, ESPP, Stock Purchase, CFO, David O'Toole, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.